Family Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Family Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-13,500	Closed	-$23K	–	78
2018 Q2	$23K	Buy	+13,500	New	+$23.3K	0.01%	75
2018 Q1	–	Sell	-11,500	Closed	-$26K	–	72
2017 Q4	$26K	Sell	11,500 -69,000	-86%	-$172K	0.02%	57
2017 Q3	$233K	Buy	80,500 +39,000	+94%	+$133K	0.16%	57
2017 Q2	$185K	Hold	41,500	–	–	0.13%	57
2017 Q1	$193K	Buy	41,500 +25,500	+159%	+$148K	0.13%	56
2016 Q4	$97K	Buy	+16,000	New	+$83.6K	0.07%	61

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Family Management's SGYP Position: Q3 2018 in Review

Family Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2018, closing a stake of 13,500 shares — an estimated $23K sold.

Family Management first reported a position in SGYP in Q4 2016 and held it in 6 quarters. The position peaked at $233K in Q3 2017. 133 funds tracked by Wall St. Rank hold SGYP as of Q3 2018.

Family Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2018 after selling out during the quarter.
Family Management sold 13,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2018, an estimated $23K.
Family Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and held it in 6 quarters.
Family Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $233K in Q3 2017.
133 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2018.

Based on Family Management's 13F filing for Q3 2018, filed 13 Nov 2018.